Cardax, Inc. (CDXI) SEC Filing 8-K Material Event for the period ending Wednesday, October 2, 2019

Cardax, Inc.

CIK: 1544238 Ticker: CDXI

View differences made from one to another to evaluate Cardax, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cardax, Inc..


Assess how Cardax, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cardax, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: CDXI
CIK: 1544238
Form Type: 8-K Corporate News
Accession Number: 0001493152-19-015243
Submitted to the SEC: Tue Oct 08 2019 4:30:14 PM EST
Accepted by the SEC: Tue Oct 08 2019
Period: Wednesday, October 2, 2019
Industry: Pharmaceutical Preparations
  1. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: